The 280-kD cation-independent mannose-6-phosphate receptor (MPR) has been shown to play a role in endocytic uptake of granzyme B, since target cells overexpressing MPR have an increased sensitivity to granzyme B–mediated apoptosis. On this basis, it has been proposed that cells lacking MPR are poor targets for cytotoxic lymphocytes that mediate allograft rejection or tumor immune surveillance. In the present study, we report that the uptake of granzyme B into target cells is independent of MPR. We used HeLa cells overexpressing a dominant-negative mutated (K44A) form of dynamin and mouse fibroblasts overexpressing or lacking MPR to show that the MPR/clathrin/dynamin pathway is not required for granzyme B uptake. Consistent with this observation, cells lacking the MPR/clathrin pathway remained sensitive to granzyme B. Exposure of K44A-dynamin–overexpressing and wild-type HeLa cells to granzyme B with sublytic perforin resulted in similar apoptosis in the two cell populations, both in short and long term assays. Granzyme B uptake into MPR-overexpressing L cells was more rapid than into MPR-null L cells, but the receptor-deficient cells took up granzyme B through fluid phase micropinocytosis and remained sensitive to it. Contrary to previous findings, we also demonstrated that mouse tumor allografts that lack MPR expression were rejected as rapidly as tumors that overexpress MPR. Entry of granzyme B into target cells and its intracellular trafficking to induce target cell death in the presence of perforin are therefore not critically dependent on MPR or clathrin/dynamin-dependent endocytosis.
Skip Nav Destination
Article navigation
20 January 2003
Article Contents
Article|
January 21 2003
A clathrin/dynamin- and mannose-6-phosphate receptor–independent pathway for granzyme B–induced cell death
Joseph A. Trapani,
Joseph A. Trapani
1Cancer Immunology Laboratory, Peter MacCallum Cancer Institute, Melbourne 8006, Australia
Search for other works by this author on:
Vivien R. Sutton,
Vivien R. Sutton
1Cancer Immunology Laboratory, Peter MacCallum Cancer Institute, Melbourne 8006, Australia
Search for other works by this author on:
Kevin Y.T. Thia,
Kevin Y.T. Thia
1Cancer Immunology Laboratory, Peter MacCallum Cancer Institute, Melbourne 8006, Australia
Search for other works by this author on:
Yu Qin Li,
Yu Qin Li
4Molecular Immunogenetics Laboratory, Austin Research Institute, Heidelberg 3084, Australia
Search for other works by this author on:
Christopher J. Froelich,
Christopher J. Froelich
3Department of Medicine, Northwestern University, Evanston, IL 60201
Search for other works by this author on:
David A. Jans,
David A. Jans
2Nuclear Signalling Laboratory, Department of Biochemistry and Molecular Biology, Monash University, Clayton 3800, Australia
Search for other works by this author on:
Mauro S. Sandrin,
Mauro S. Sandrin
4Molecular Immunogenetics Laboratory, Austin Research Institute, Heidelberg 3084, Australia
Search for other works by this author on:
Kylie A. Browne
Kylie A. Browne
1Cancer Immunology Laboratory, Peter MacCallum Cancer Institute, Melbourne 8006, Australia
Search for other works by this author on:
Joseph A. Trapani
1Cancer Immunology Laboratory, Peter MacCallum Cancer Institute, Melbourne 8006, Australia
Vivien R. Sutton
1Cancer Immunology Laboratory, Peter MacCallum Cancer Institute, Melbourne 8006, Australia
Kevin Y.T. Thia
1Cancer Immunology Laboratory, Peter MacCallum Cancer Institute, Melbourne 8006, Australia
Yu Qin Li
4Molecular Immunogenetics Laboratory, Austin Research Institute, Heidelberg 3084, Australia
Christopher J. Froelich
3Department of Medicine, Northwestern University, Evanston, IL 60201
David A. Jans
2Nuclear Signalling Laboratory, Department of Biochemistry and Molecular Biology, Monash University, Clayton 3800, Australia
Mauro S. Sandrin
4Molecular Immunogenetics Laboratory, Austin Research Institute, Heidelberg 3084, Australia
Kylie A. Browne
1Cancer Immunology Laboratory, Peter MacCallum Cancer Institute, Melbourne 8006, Australia
Address correspondence to Joseph A. Trapani, Cancer Immunology Laboratory, Peter MacCallum Cancer Institute, Locked Bag 1, A'Beckett St., Melbourne 8006, Australia. Tel.: 61-3-9656-3726. Fax: 61-3-9656-1411. E-mail: [email protected]
D.A. Jans and M.S. Sandrin contributed equally to this work.
*
Abbreviations used in this paper: CL, cytotoxic lymphocyte; CTL, cytotoxic T lymphocyte; G6P, glucose-6-phosphate; M6P, mannose-6-phosphate; MPR, 280-kD cation-independent M6P receptor; PLO, pneumococcal pneumolysin; tet, tetracycline.
Received:
October 28 2002
Revision Received:
November 25 2002
Accepted:
November 26 2002
Online ISSN: 1540-8140
Print ISSN: 0021-9525
The Rockefeller University Press
2003
J Cell Biol (2003) 160 (2): 223–233.
Article history
Received:
October 28 2002
Revision Received:
November 25 2002
Accepted:
November 26 2002
Citation
Joseph A. Trapani, Vivien R. Sutton, Kevin Y.T. Thia, Yu Qin Li, Christopher J. Froelich, David A. Jans, Mauro S. Sandrin, Kylie A. Browne; A clathrin/dynamin- and mannose-6-phosphate receptor–independent pathway for granzyme B–induced cell death . J Cell Biol 20 January 2003; 160 (2): 223–233. doi: https://doi.org/10.1083/jcb.200210150
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement
Advertisement